Gene · 1500
Papers4,443
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,443
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Latest advances in the study of non-coding RNA-mediated circadian rhythm disorders causing endometrial cancer. | Front Oncol | 2023 | 38074657 | PubTator, text mining | PubMed |
| Comparative RNA-Seq Analysis Revealed Tissue-Specific Splicing Variations during the Generation of the PDX Model. | Int J Mol Sci | 2023 | 38069324 | PubTator, text mining | PubMed |
| Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives. | Int J Mol Sci | 2023 | 38069210 | PubTator, text mining | PubMed |
| Emerging Microfluidic Tools for Simultaneous Exosomes and Cargo Biosensing in Liquid Biopsy: New Integrated Miniaturized FFF-Assisted Approach for Colon Cancer Diagnosis. | Sensors (Basel) | 2023 | 38067805 | PubTator, text mining | PubMed |
| The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis. | Mol Cancer | 2023 | 38037077 | PubTator, text mining | PubMed |
| Cdh11: Roles in different diseases and potential value in disease diagnosis and treatment. | Biochem Biophys Rep | 2023 | 38034129 | PubTator, text mining | PubMed |
| The roles of tissue-resident macrophages in sepsis-associated organ dysfunction. | Heliyon | 2023 | 38027963 | PubTator, text mining | PubMed |
| A Case of ALK-Positive Anaplastic Large Cell Lymphoma of the Male Breast. | Int Med Case Rep J | 2023 | 38020577 | PubTator, text mining | PubMed |
| High-throughput proteomics uncovers exercise training and type 2 diabetes-induced changes in human white adipose tissue. | Sci Adv | 2023 | 38019916 | PubTator, text mining | PubMed |
| Breaking barriers: exploring mechanisms behind opening the blood-brain barrier. | Fluids Barriers CNS | 2023 | 38017530 | PubTator, text mining | PubMed |
| The Pharmacological Implications of Flavopiridol: An Updated Overview. | Molecules | 2023 | 38005250 | PubTator, text mining | PubMed |
| Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics. | Genes (Basel) | 2023 | 38002944 | PubTator, text mining | PubMed |
| Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights. | Cancers (Basel) | 2023 | 38001750 | PubTator, text mining | PubMed |
| Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer. | Breast Cancer Res | 2023 | 37993928 | PubTator, text mining | PubMed |
| Role of Exosomal Non-Coding RNA in the Tumour Microenvironment of Genitourinary System Tumours. | Technol Cancer Res Treat | 2023 | 37981789 | PubTator, text mining | PubMed |
| ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma. | Mol Cancer | 2023 | 37980532 | PubTator, text mining | PubMed |
| Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype. | Nat Commun | 2023 | 37973922 | PubTator, text mining | PubMed |
| Cannflavins A and B with Anti-Ferroptosis, Anti-Glycation, and Antioxidant Activities Protect Human Keratinocytes in a Cell Death Model with Erastin and Reactive Carbonyl Species. | Nutrients | 2023 | 37960218 | PubTator, text mining | PubMed |
| Mechanisms Underlying Rare Inherited Pediatric Retinal Vascular Diseases: FEVR, Norrie Disease, Persistent Fetal Vascular Syndrome. | Cells | 2023 | 37947657 | PubTator, text mining | PubMed |
| Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer's Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention. | ACS Omega | 2023 | 37929080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1500/papers?page=11